DD125484A5 - - Google Patents

Info

Publication number
DD125484A5
DD125484A5 DD190061A DD19006175A DD125484A5 DD 125484 A5 DD125484 A5 DD 125484A5 DD 190061 A DD190061 A DD 190061A DD 19006175 A DD19006175 A DD 19006175A DD 125484 A5 DD125484 A5 DD 125484A5
Authority
DD
German Democratic Republic
Application number
DD190061A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD125484A5 publication Critical patent/DD125484A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DD190061A 1974-12-13 1975-12-11 DD125484A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2458965A DE2458965C3 (de) 1974-12-13 1974-12-13 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
DD125484A5 true DD125484A5 (enExample) 1977-04-20

Family

ID=5933305

Family Applications (1)

Application Number Title Priority Date Filing Date
DD190061A DD125484A5 (enExample) 1974-12-13 1975-12-11

Country Status (27)

Country Link
US (1) US4051252A (enExample)
JP (1) JPS5182266A (enExample)
AT (1) AT343653B (enExample)
BE (1) BE836528A (enExample)
CA (1) CA1059523A (enExample)
CH (1) CH622250A5 (enExample)
CS (1) CS189731B2 (enExample)
DD (1) DD125484A5 (enExample)
DE (1) DE2458965C3 (enExample)
DK (1) DK137082C (enExample)
ES (1) ES443429A1 (enExample)
FI (1) FI753493A7 (enExample)
FR (1) FR2293928A1 (enExample)
GB (1) GB1490306A (enExample)
HK (1) HK52580A (enExample)
HU (1) HU173557B (enExample)
IE (1) IE42208B1 (enExample)
IL (1) IL48642A (enExample)
KE (1) KE3078A (enExample)
LU (1) LU73993A1 (enExample)
NL (1) NL7514521A (enExample)
NO (1) NO145382C (enExample)
PL (1) PL99858B1 (enExample)
SE (1) SE419645B (enExample)
SU (1) SU604487A3 (enExample)
YU (1) YU315275A (enExample)
ZA (1) ZA757777B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431657A (en) * 1982-05-24 1984-02-14 Ayerst, Mckenna & Harrison Inc. Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
KR20010086657A (ko) * 2000-03-02 2001-09-15 성재갑 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
CN1926132B (zh) * 2000-09-15 2010-12-29 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的吡唑化合物
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
EP1698627A1 (en) * 2000-09-15 2006-09-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
DK1318997T3 (da) * 2000-09-15 2006-09-25 Vertex Pharma Pyrazolforbindelser der er nyttige som proteinkinase-inhibitorer
HUP0400639A3 (en) 2000-12-21 2010-03-29 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors and pharmaceutical compositions containing them
KR100406634B1 (ko) * 2001-03-12 2003-11-20 주식회사 엘지생명과학 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
ES2357502T3 (es) 2001-09-26 2011-04-27 Pfizer Italia S.R.L. Derivados de aminoindazol activos como inhibidores de quinasa, procedimiento para su preparación y composiciones farmaceuticas que los contienen.
KR20040084896A (ko) * 2002-02-06 2004-10-06 버텍스 파마슈티칼스 인코포레이티드 Ｇｓｋ-3의 억제제로서 유용한 헤테로아릴 화합물
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ATE468336T1 (de) 2002-03-15 2010-06-15 Vertex Pharma Azolylaminoazine als proteinkinasehemmer
EP1506176B1 (en) 2002-05-17 2013-04-24 Pfizer Italia S.r.l. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
DE60308387T2 (de) 2002-08-02 2007-09-20 Vertex Pharmaceuticals Inc., Cambridge Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
JP2006512313A (ja) * 2002-10-31 2006-04-13 アムジェン インコーポレイテッド 抗炎症剤
WO2004072029A2 (en) 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
JP2007513184A (ja) * 2003-12-04 2007-05-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼのインヒビターとして有用なキノキサリン
DE102004005172A1 (de) 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
AU2006279376B2 (en) 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
TW200734327A (en) 2005-11-03 2007-09-16 Vertex Pharma Aminopyrimidines useful as kinase inhibitors
JP2009533474A (ja) * 2006-04-14 2009-09-17 アボット・ラボラトリーズ バニロイドサブタイプ１（ｖｒ１）受容体を阻害するインダゾリルウレアの製造方法
WO2008057940A1 (en) 2006-11-02 2008-05-15 Vertex Pharmaceuticals Incorporated Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
WO2008077086A1 (en) 2006-12-19 2008-06-26 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
EP2137183B1 (en) 2007-03-09 2011-09-28 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
WO2008112642A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
EP2134709A1 (en) 2007-03-09 2009-12-23 Vertex Pharmaceuticals, Inc. Aminopyridines useful as inhibitors of protein kinases
JP2010523700A (ja) 2007-04-13 2010-07-15 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼインヒビターとして有用なアミノピリミジン
CN101679378A (zh) 2007-05-02 2010-03-24 沃泰克斯药物股份有限公司 用作激酶抑制剂的噻唑和吡唑
CN101801959A (zh) 2007-05-02 2010-08-11 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
AU2008247595A1 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
AU2008257044A1 (en) * 2007-05-24 2008-12-04 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
AR067762A1 (es) 2007-07-31 2009-10-21 Vertex Pharma Proceso para preparar 5-fluoro-1h-pirazolo (3,4-b) piridin-3-amina y derivados de la misma
AU2009288200A1 (en) * 2008-09-03 2010-03-11 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
DE102009004245A1 (de) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
KR102137714B1 (ko) 2012-07-24 2020-07-27 바이알 - 포르텔라 앤드 씨에이 에스에이 요소 화합물 및 효소 억제제로서 이들의 용도
EP2882712A2 (en) * 2012-07-27 2015-06-17 BIAL - Portela & Cª S.A. Process for the synthesis of substituted urea compounds
AU2014293731B2 (en) 2013-07-24 2018-03-08 Bial - Portela & Ca, S.A. Imidazolecarboxamides and their use as FAAH inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
CH397698A (de) * 1961-09-08 1965-08-31 Siegfried Ag Verfahren zur Herstellung neuer 1-Carbamyl-indazole
US3277100A (en) * 1963-05-31 1966-10-04 Du Pont Novel substituted pyrazoles
NL6707299A (enExample) * 1966-07-16 1968-01-17
DE1770649A1 (de) * 1968-06-15 1971-11-11 Bayer Ag Substituierte 3-Amino-indazole

Also Published As

Publication number Publication date
IL48642A0 (en) 1976-02-29
NO754024L (enExample) 1976-06-15
NL7514521A (nl) 1976-06-15
GB1490306A (en) 1977-11-02
JPS5182266A (en) 1976-07-19
PL99858B1 (pl) 1978-08-31
SU604487A3 (ru) 1978-04-25
ZA757777B (en) 1976-11-24
ES443429A1 (es) 1977-04-16
CH622250A5 (enExample) 1981-03-31
IE42208L (en) 1976-06-13
DK567275A (da) 1976-06-14
DK137082C (da) 1978-06-19
SE419645B (sv) 1981-08-17
DE2458965B2 (de) 1979-02-22
CS189731B2 (en) 1979-04-30
YU315275A (en) 1982-02-28
HK52580A (en) 1980-09-26
ATA939775A (de) 1977-10-15
IL48642A (en) 1979-12-30
AT343653B (de) 1978-06-12
DE2458965C3 (de) 1979-10-11
AU8717075A (en) 1977-06-09
NO145382B (no) 1981-11-30
LU73993A1 (enExample) 1976-11-11
SE7513990L (sv) 1976-06-14
DK137082B (da) 1978-01-16
FR2293928A1 (fr) 1976-07-09
NO145382C (no) 1982-03-10
FR2293928B1 (enExample) 1979-09-21
CA1059523A (en) 1979-07-31
IE42208B1 (en) 1980-06-18
DE2458965A1 (de) 1976-06-16
FI753493A7 (enExample) 1976-06-14
HU173557B (hu) 1979-06-28
US4051252A (en) 1977-09-27
BE836528A (fr) 1976-06-11
KE3078A (en) 1980-10-03

Similar Documents

Publication Publication Date Title
FI753493A7 (enExample)
AU495920B2 (enExample)
AU495028B2 (enExample)
DK109174A (enExample)
AU7253374A (enExample)
AU7465674A (enExample)
AU7478474A (enExample)
BE836983A (enExample)
BG19662A1 (enExample)
AU480559A (enExample)
AU480622A (enExample)
AU480660A (enExample)
AU480879A (enExample)
BG20062A1 (enExample)
AU481044A (enExample)
AU481265A (enExample)
AU481500A (enExample)
AU481523A (enExample)
AU480187A (enExample)
AU481545A (enExample)
AU481765A (enExample)
AU482294A (enExample)
AU482307A (enExample)
BE830202A (enExample)
AU479768A (enExample)